GLOBAL HEALTH SCIENCES INC
10-Q, EX-27.1, 2000-08-11
MEDICINAL CHEMICALS & BOTANICAL PRODUCTS
Previous: GLOBAL HEALTH SCIENCES INC, 10-Q, 2000-08-11
Next: GB&T BANCSHARES INC, 10-Q, 2000-08-11



<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<MULTIPLIER>  1,000

<S>                           <C>             <C>              <C>             <C>
<PERIOD-TYPE>                    3-MOS           3-MOS            3-MOS           3-MOS
<FISCAL-YEAR-END>             DEC-31-2000     DEC-31-2000      DEC-31-2000     DEC-31-2000
<PERIOD-END>                  MAR-31-1999     MAR-31-2000      JUN-30-1999     JUN-30-2000
<CASH>                             13,687          12,578            8,324           1,495
<SECURITIES>                            0               0                0               0
<RECEIVABLES>                      15,460          17,851           17,900          16,055
<ALLOWANCES>                          574             685              567           1,164
<INVENTORY>                        17,181          25,339           23,043          25,565
<CURRENT-ASSETS>                   48,354          57,134           51,921          42,722
<PP&E>                             23,883          33,296           28,807          34,779
<DEPRECIATION>                     10,375          12,528           10,839          13,428
<TOTAL-ASSETS>                    211,568         193,677          211,395         171,087
<CURRENT-LIABILITIES>              67,663          75,545           75,327          65,700
<BONDS>                           218,998         219,658          219,163         219,824
                   0               0                0               0
                             0               0                0               0
<COMMON>                              473             473              473             473
<OTHER-SE>                       (75,566)       (101,999)         (83,568)       (114,437)
<TOTAL-LIABILITY-AND-EQUITY>      211,568         193,677          211,395         171,087
<SALES>                                 0               0                0               0
<TOTAL-REVENUES>                   52,096          71,167           57,615          49,239
<CGS>                              36,833          53,943           40,647          38,236
<TOTAL-COSTS>                      36,833          53,943           40,647          38,236
<OTHER-EXPENSES>                    5,120           6,476           14,171          15,746
<LOSS-PROVISION>                        0               0                0               0
<INTEREST-EXPENSE>                  7,192           7,601            7,313           8,262
<INCOME-PRETAX>                   (5,232)         (5,036)          (4,516)        (13,005)
<INCOME-TAX>                          23              25               33            (95)
<INCOME-CONTINUING>               (5,255)         (5,061)          (4,549)        (12,910)
<DISCONTINUED>                          0               0                0               0
<EXTRAORDINARY>                         0               0                0               0
<CHANGES>                               0               0                0               0
<NET-INCOME>                      (5,255)         (5,061)          (4,549)        (12,910)
<EPS-BASIC>                             0               0                0               0
<EPS-DILUTED>                           0               0                0               0




</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission